FN-1501-propionic acid is primarily utilized in the development of pharmaceutical compounds, particularly in the synthesis of novel drug candidates. Its structure makes it a valuable intermediate in the creation of molecules targeting specific biological pathways, such as cancer therapy. Researchers are exploring its potential in inhibiting certain enzymes or receptors involved in tumor growth, making it a promising component in oncology research. Additionally, it may be used in the design of anti-inflammatory or antimicrobial agents due to its functional groups that can interact with biological targets. Its application is largely confined to preclinical studies, where it contributes to the discovery of new therapeutic agents with improved efficacy and safety profiles.